Anuradha Rao

Where is Omicron? Comparison of SARS-CoV-2 RT-PCR and Antigen Test Sensitivity at Commonly Sampled Anatomic Sites Over the Course of Disease

Adrianna L Westbrook, J. Waggoner, A. Piantadosi, 2022, medRxiv.

COVID‐19 will not “magically disappear”: Why Access to Widespread Testing is Paramount

D. Wechsler, G. Martin, W. Lam, 2020, American journal of hematology.

Deep mutational scanning identifies SARS-CoV-2 Nucleocapsid escape mutations of currently available rapid antigen tests

E. Ortlund, F. Frank, W. Hudson, 2022, Cell.

The RADx Tech Test Verification Core and the ACME POCT in the Evaluation of COVID-19 Testing Devices: A Model for Progress and Change

B. Buchholz, D. McManus, G. Martin, 2021, IEEE Open Journal of Engineering in Medicine and Biology.

Assessment of the Abbott BinaxNOW SARS-CoV-2 rapid antigen test against viral variants of concern

R. Schinazi, A. Piantadosi, T. Pribyl, 2022, iScience.

Multidisciplinary assessment of the Abbott BinaxNOW SARS-CoV-2 point-of-care antigen test in the context of emerging viral variants and self-administration

G. Martin, N. Schoof, E. Tyburski, 2021, Scientific Reports.

148. Single-amplicon, Multiplex Real-time RT-PCR with Tiled Probes to Detect SARS-CoV-2 spike Mutations Associated with Variants of Concern

J. Waggoner, A. Piantadosi, C. Kraft, 2021, Open Forum Infectious Diseases.